XML 73 R48.htm IDEA: XBRL DOCUMENT v3.25.0.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Revenue by Type (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]      
Revenue $ 837.6 $ 753.2 $ 678.4
Hereditary Cancer      
Disaggregation of Revenue [Line Items]      
Revenue 364.5 327.8 305.5
Tumor Profiling      
Disaggregation of Revenue [Line Items]      
Revenue 125.8 135.6 128.6
Prenatal      
Disaggregation of Revenue [Line Items]      
Revenue 177.1 151.3 116.4
Pharmacogenomics      
Disaggregation of Revenue [Line Items]      
Revenue 170.2 138.5 127.6
Autoimmune      
Disaggregation of Revenue [Line Items]      
Revenue $ 0.0 $ 0.0 $ 0.3